Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
SciClone Pharmaceuticals
SciClone Pharmaceuticals
(SCLN)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Thymalfasin
hiv infections
,
acquired immunodeficiency syndrome
,
endometrial neoplasms
,
uterine cervical neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
small cell lung carcinoma
,
melanoma
,
carcinoma
,
lymphopenia
,
esophageal neoplasms
,
radiotherapy
,
hematologic neoplasms
,
stomach neoplasms
,
adenocarcinoma
,
adenocarcinoma of lung
,
breast neoplasms
,
renal cell carcinoma
,
hepatocellular carcinoma
,
chronic kidney failure
,
radiosurgery
,
neoplasms
,
pancreatic ductal carcinoma
,
hepatitis
,
hepatitis a
,
colorectal neoplasms
,
chronic hepatitis c
,
covid-19
,
hepatitis c
,
coronavirus infections
,
chronic hepatitis b
,
hepatitis b
,
sepsis
,
liver neoplasms
,
liver cirrhosis
,
toxemia
,
pancreatitis
,
acute necrotizing pancreatitis
,
musculoskeletal pain
,
respiratory distress syndrome
,
acute lung injury
,
newborn respiratory distress syndrome
,
syndrome
,
aortic dissection
,
inflammation
,
liver failure
,
acute aortic syndrome
,
cardiopulmonary bypass
,
heart diseases
,
rheumatic heart disease
,
immunotherapy
,
rheumatic diseases
,
squamous cell carcinoma
,
esophageal squamous cell carcinoma
,
aortic aneurysm
GOLOTIMOD
hepatitis c
,
chronic hepatitis c
,
hepatitis
,
chronic hepatitis
,
head and neck neoplasms
,
stomatitis
,
mucositis
,
hepatitis a
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use